Stromal Demarcation Line: is it Predictive for Cross-Linking Efficiency?
STROMA-CROSS
1 other identifier
observational
36
0 countries
N/A
Brief Summary
To assess the association between stromal demarcation line after collagen crosslinking (CXL) for progressive keratoconus and mid-term (6 month) refractive, topographic and clinical outcomes of CXL
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 25, 2016
CompletedFirst Posted
Study publicly available on registry
August 30, 2016
CompletedSeptember 15, 2016
August 1, 2016
2 months
August 25, 2016
September 14, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
visibility of the stromal demarcation line
month 1
Study Arms (1)
patients treated with CXL
Eligibility Criteria
All consecutive patients treated with CXL between March 2014 and March 2015 were included
You may qualify if:
- patients treated with CXL
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2016
First Posted
August 30, 2016
Study Start
October 1, 2015
Primary Completion
December 1, 2015
Study Completion
March 1, 2016
Last Updated
September 15, 2016
Record last verified: 2016-08